AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
PROSPECTS FOR A PROPHYLACTIC HPV VACCINE - RATIONALE AND FUTURE IMPLICATIONS FOR CERVICAL-CANCER SCREENING
Authors: SHERMAN ME SCHIFFMAN MH STRICKLER H HILDESHEIM A
Citation: Me. Sherman et al., PROSPECTS FOR A PROPHYLACTIC HPV VACCINE - RATIONALE AND FUTURE IMPLICATIONS FOR CERVICAL-CANCER SCREENING, Diagnostic cytopathology, 18(1), 1998, pp. 5-9
A SURVEY OF HUMAN-PAPILLOMAVIRUS-16 ANTIBODIES IN PATIENTS WITH EPITHELIAL CANCERS
Authors: STRICKLER HD SCHIFFMAN MH SHAH KV RABKIN CS SCHILLER JT WACHOLDER S CLAYMAN B VISCIDI RP
Citation: Hd. Strickler et al., A SURVEY OF HUMAN-PAPILLOMAVIRUS-16 ANTIBODIES IN PATIENTS WITH EPITHELIAL CANCERS, European journal of cancer prevention, 7(4), 1998, pp. 305-313
REVIEW OF THE BETHESDA-SYSTEM ATLAS DOES NOT IMPROVE DIAGNOSTIC REPRODUCIBILITY OR ACCURACY
Authors: SMITH AE SCOTT D FASER C SNELL J TABBARRA S THOMPSON J DWORKIN L OLSON J SHERMAN ME SCHIFFMAN MH
Citation: Ae. Smith et al., REVIEW OF THE BETHESDA-SYSTEM ATLAS DOES NOT IMPROVE DIAGNOSTIC REPRODUCIBILITY OR ACCURACY, Modern pathology, 11(1), 1998, pp. 44-44
EVIDENCE FOR AT LEAST 2 DISTINCT GROUPS OF HUMORAL IMMUNE-REACTIONS TO PAPILLOMAVIRUS ANTIGENS IN WOMEN WITH SQUAMOUS INTRAEPITHELIAL LESIONS
Authors: STRICKLER HD SCHIFFMAN MH EKLUND C GLASS AG SCOTT DR SHERMAN ME WACHOLDER S KURMAN RJ MANOS MM SCHILLER JT DILLNER J
Citation: Hd. Strickler et al., EVIDENCE FOR AT LEAST 2 DISTINCT GROUPS OF HUMORAL IMMUNE-REACTIONS TO PAPILLOMAVIRUS ANTIGENS IN WOMEN WITH SQUAMOUS INTRAEPITHELIAL LESIONS, Cancer epidemiology, biomarkers & prevention, 6(3), 1997, pp. 183-188
IMMUNE ACTIVATION IN CERVICAL NEOPLASIA - CROSS-SECTIONAL ASSOCIATIONBETWEEN PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS AND DISEASE
Authors: HILDESHEIM A SCHIFFMAN MH TSUKUI T SWANSON CA LUCCI J SCOTT DR GLASS AG RUSH BB LORINCZ AT CORRIGAN A BURK RD HELGESEN K HOUGHTEN RA SHERMAN ME KURMAN RJ BERZOFSKY JA KRAMER TR
Citation: A. Hildesheim et al., IMMUNE ACTIVATION IN CERVICAL NEOPLASIA - CROSS-SECTIONAL ASSOCIATIONBETWEEN PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS AND DISEASE, Cancer epidemiology, biomarkers & prevention, 6(10), 1997, pp. 807-813
IS HUMAN-PAPILLOMAVIRUS AN INFECTIOUS CAUSE OF NON-CERVICAL ANOGENITAL TRACT CANCERS
Authors: STRICKLER HD SCHIFFMAN MH
Citation: Hd. Strickler et Mh. Schiffman, IS HUMAN-PAPILLOMAVIRUS AN INFECTIOUS CAUSE OF NON-CERVICAL ANOGENITAL TRACT CANCERS, BMJ. British medical journal, 315(7109), 1997, pp. 620-621
EVALUATION OF PAPNET TESTING AS AN ANCILLARY TOOL TO CLARIFY THE STATUS OF THE ATYPICAL CERVICAL SMEAR
Authors: SHERMAN ME SCHIFFMAN MH MANGO LJ KELLY D ACOSTA D CASON Z ELGERT P ZALESKI S SCOTT DR KURMAN RJ STOLER M LORINCZ AT
Citation: Me. Sherman et al., EVALUATION OF PAPNET TESTING AS AN ANCILLARY TOOL TO CLARIFY THE STATUS OF THE ATYPICAL CERVICAL SMEAR, Modern pathology, 10(6), 1997, pp. 564-571
COMPARISON OF THE HYBRID CAPTURE TUBE TEST AND PCR FOR DETECTION OF HUMAN-PAPILLOMAVIRUS DNA IN CERVICAL SPECIMENS
Authors: COPE JU HILDESHEIM A SCHIFFMAN MH MANOS MM LORINCZ AT BURK RD GLASS AG GREER C BUCKLAND J HELGESEN K SCOTT DR SHERMAN ME KURMAN RJ LIAW KL
Citation: Ju. Cope et al., COMPARISON OF THE HYBRID CAPTURE TUBE TEST AND PCR FOR DETECTION OF HUMAN-PAPILLOMAVIRUS DNA IN CERVICAL SPECIMENS, Journal of clinical microbiology, 35(9), 1997, pp. 2262-2265
ASCUS VS HSIL - EVALUATION OF THE MORPHOLOGIC FEATURES
Authors: TABBARA SO SHERMAN ME SCHIFFMAN MH GLASS AG CADELL DM RUSH BB SCOTT DR KURMAN RJ LORINCZ A MANOS MM
Citation: So. Tabbara et al., ASCUS VS HSIL - EVALUATION OF THE MORPHOLOGIC FEATURES, Laboratory investigation, 76(1), 1997, pp. 212-212
HUMAN-PAPILLOMAVIRUS TYPE-52 AND TYPE-58 ARE PREVALENT IN CERVICAL-CANCER FROM CHINESE WOMEN
Authors: LIAW KL HSING AW SCHIFFMAN MH YOU SL ZHANG T BURK R CHEN CJ
Citation: Kl. Liaw et al., HUMAN-PAPILLOMAVIRUS TYPE-52 AND TYPE-58 ARE PREVALENT IN CERVICAL-CANCER FROM CHINESE WOMEN, International journal of cancer, 73(5), 1997, pp. 775-776
CERVICAL SPECIMENS COLLECTED IN LIQUID BUFFER ARE SUITABLE FOR BOTH CYTOLOGIC SCREENING AND ANCILLARY HUMAN-PAPILLOMAVIRUS TESTING
Authors: SHERMAN ME SCHIFFMAN MH LORINCZ AT HERRERO R HUTCHINSON ML BRATTI C ZAHNISER D MORALES J HILDESHEIM A HELGESEN K KELLY D ALFARO M MENA F BALMACEDA I MANGO L GREENBERG M
Citation: Me. Sherman et al., CERVICAL SPECIMENS COLLECTED IN LIQUID BUFFER ARE SUITABLE FOR BOTH CYTOLOGIC SCREENING AND ANCILLARY HUMAN-PAPILLOMAVIRUS TESTING, Cancer cytopathology, 81(2), 1997, pp. 89-97
SURROGATE END-POINTS IN CANCER-RESEARCH - A CRITIQUE
Authors: SCHATZKIN A FREEDMAN LS DORGAN J MCSHANE LM SCHIFFMAN MH DAWSEY SM
Citation: A. Schatzkin et al., SURROGATE END-POINTS IN CANCER-RESEARCH - A CRITIQUE, Cancer epidemiology, biomarkers & prevention, 5(12), 1996, pp. 947-953
EPIDEMIOLOGIC DETERMINANTS OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN CERVICAL HPV-16 DNA-POSITIVE ANDDNA-NEGATIVE WOMEN
Authors: WIDEROFF L SCHIFFMAN MH HOOVER R TARONE RE NONNENMACHER B HUBBERT N KIRNBAUER R GREER CE LORINCZ AT MANOS MM GLASS AG SCOTT DR SHERMAN ME BUCKLAND J LOWY D SCHILLER J
Citation: L. Wideroff et al., EPIDEMIOLOGIC DETERMINANTS OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN CERVICAL HPV-16 DNA-POSITIVE ANDDNA-NEGATIVE WOMEN, The Journal of infectious diseases, 174(5), 1996, pp. 937-943
SEROLOGY OF HUMAN PAPILLOMAVIRUS TYPE-16 INFECTIONS - WHERE ANGELS FEAR TO TREAD - REPLY
Authors: WIDEROFF L SCHILLER J KIRNBAUER R SCHIFFMAN MH TARONE RE MANOS MM LOWY D
Citation: L. Wideroff et al., SEROLOGY OF HUMAN PAPILLOMAVIRUS TYPE-16 INFECTIONS - WHERE ANGELS FEAR TO TREAD - REPLY, The Journal of infectious diseases, 174(1), 1996, pp. 238-239
TYPE-SPECIFIC PREVALENCE OF HUMAN PAPILLOMAVIRUS DNA AMONG JAMAICAN COLPOSCOPY PATIENTS
Authors: RATTRAY C STRICKLER HD ESCOFFERY C CRANSTON B BROWN C MANNS A SCHIFFMAN MH PALEFSKY JM HANCHARD B BLATTNER WA
Citation: C. Rattray et al., TYPE-SPECIFIC PREVALENCE OF HUMAN PAPILLOMAVIRUS DNA AMONG JAMAICAN COLPOSCOPY PATIENTS, The Journal of infectious diseases, 173(3), 1996, pp. 718-721
INTERLEUKIN-2 PRODUCTION IN-VITRO BY PERIPHERAL LYMPHOCYTES IN RESPONSE TO HUMAN PAPILLOMAVIRUS-DERIVED PEPTIDES - CORRELATION WITH CERVICAL PATHOLOGY
Authors: TSUKUI T HILDESHEIM A SCHIFFMAN MH LUCCI J CONTOIS D LAWLER P RUSH BB LORINCZ AT CORRIGAN A BURK RD QU WM MARSHALL MA MANN D CARRINGTON M CLERICI M SHEARER GM CARBONE DP SCOTT DR HOUGHTEN RA BERZOFSKY JA
Citation: T. Tsukui et al., INTERLEUKIN-2 PRODUCTION IN-VITRO BY PERIPHERAL LYMPHOCYTES IN RESPONSE TO HUMAN PAPILLOMAVIRUS-DERIVED PEPTIDES - CORRELATION WITH CERVICAL PATHOLOGY, Cancer research, 56(17), 1996, pp. 3967-3974
NEW EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL NEOPLASIA
Authors: SCHIFFMAN MH
Citation: Mh. Schiffman, NEW EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL NEOPLASIA, Journal of the National Cancer Institute, 87(18), 1995, pp. 1345-1347
PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
Authors: BOSCH FX MANOS MM MUNOZ N SHERMAN M JANSEN AM PETO J SCHIFFMAN MH MORENO V KURMAN R SHAH KV ALIHONOU E BAYO S MOKHTAR HC CHICAREON S DAUDT A DELOSRIOS E GHADIRIAN P KITINYA JN KOULIBALY M NGELANGEL C TINTORE LMP RIOSDALENZ JL",SARJADI,"SCHNEIDER A TAFUR L TEYSSIE AR ROLON PA TORROELLA M TAPIA AV WABINGA HR ZATONSKI W SYLLA B VIZCAINO P MAGNIN D KALDOR J GREER C WHEELER C
Citation: Fx. Bosch et al., PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE, Journal of the National Cancer Institute, 87(11), 1995, pp. 796-802
CERVICAL INTRAEPITHELIAL NEOPLASIA IS NOT ASSOCIATED WITH ELEVATED SERUM NEOPTERIN LEVELS
Authors: STRICKLER HD ESCOFFERY C RATTRAY C FUCHS D WACHTER H MANNS A SCHIFFMAN MH CRANSTON B HANCHARD B BLATTNER WA
Citation: Hd. Strickler et al., CERVICAL INTRAEPITHELIAL NEOPLASIA IS NOT ASSOCIATED WITH ELEVATED SERUM NEOPTERIN LEVELS, Cancer epidemiology, biomarkers & prevention, 4(3), 1995, pp. 295-298
EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUSES
Authors: VITTORIO CC SCHIFFMAN MH WEINSTOCK MA
Citation: Cc. Vittorio et al., EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUSES, Dermatologic clinics, 13(3), 1995, pp. 561-574
ACCURACY AND INTERLABORATORY RELIABILITY OF HUMAN PAPILLOMAVIRUS DNA TESTING BY HYBRID CAPTURE
Authors: SCHIFFMAN MH KIVIAT NB BURK RD SHAH KV DANIEL RW LEWIS R KUYPERS J MANOS MM SCOTT DR SHERMAN ME KURMAN RJ STOLER MH GLASS AG RUSH BB MIELZYNSKA I LORINCZ AT
Citation: Mh. Schiffman et al., ACCURACY AND INTERLABORATORY RELIABILITY OF HUMAN PAPILLOMAVIRUS DNA TESTING BY HYBRID CAPTURE, Journal of clinical microbiology, 33(3), 1995, pp. 545-550
EVALUATION OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IN AN INCIDENT CASE-CONTROL STUDY OF CERVICAL NEOPLASIA
Authors: WIDEROFF L SCHIFFMAN MH NONNENMACHER B HUBBERT N KIRNBAUER R GREER CE LOWY D LORINCZ AT MANOS MM GLASS AG SCOTT DR SHERMAN ME KURMAN RJ BUCKLAND J TARONE RE SCHILLER J
Citation: L. Wideroff et al., EVALUATION OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IN AN INCIDENT CASE-CONTROL STUDY OF CERVICAL NEOPLASIA, The Journal of infectious diseases, 172(6), 1995, pp. 1425-1430
HUMAN PAPILLOMAVIRUS AND CERVICAL NEOPLASIA - A CASE-CONTROL STUDY INTAIWAN
Authors: LIAW KL HSING AW CHEN CJ SCHIFFMAN MH ZHANG TY HSIEH CY GREER CE YOU SL HUANG TW WU TC OLEARY TJ SEIDMAN JD BLOT WJ MEINERT CL MANOS MM
Citation: Kl. Liaw et al., HUMAN PAPILLOMAVIRUS AND CERVICAL NEOPLASIA - A CASE-CONTROL STUDY INTAIWAN, International journal of cancer, 62(5), 1995, pp. 565-571
HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND SEVERE NEOPLASIA OF THE CERVIX IN JAMAICA
Authors: STRICKLER HD RATTRAY C ESCOFFERY C MANNS A SCHIFFMAN MH BROWN C CRANSTON B HANCHARD B PALEFSKY JM BLATTNER WA
Citation: Hd. Strickler et al., HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND SEVERE NEOPLASIA OF THE CERVIX IN JAMAICA, International journal of cancer, 61(1), 1995, pp. 23-26
THE EPIDEMIOLOGY OF CERVICAL CARCINOGENESIS
Authors: SCHIFFMAN MH BRINTON LA
Citation: Mh. Schiffman et La. Brinton, THE EPIDEMIOLOGY OF CERVICAL CARCINOGENESIS, Cancer, 76(10), 1995, pp. 1888-1901
Risultati: 1-25 | 26-40